RecruitingPhase 2NCT06518434

A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer Patients

A Phase 2a Study on the Anti-tumoral Effect of Cannabis Oil (THC 10% / CBD 5%) in Patients With Advanced Untreatable Hepatocellular Carcinoma


Sponsor

University Medical Center Groningen

Enrollment

20 participants

Start Date

Apr 15, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

to study the anti-tumor effect of cannabis oil (THC10% / CBD5%) in untreatable HCC patients based on mRECIST and RECIST criteria


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This pilot study is testing cannabis oil in people with advanced liver cancer (hepatocellular carcinoma) who cannot receive or have declined standard treatments. The goal is to see whether cannabis oil is safe, tolerable, and has any effect on quality of life or tumor progression in this specific group. **You may be eligible if...** - You are 18 or older - You have a confirmed diagnosis of hepatocellular carcinoma (a type of liver cancer) - Your liver is either not cirrhotic, or has mild cirrhosis (Child Pugh A) - Your brain function is normal or near-normal (hepatic encephalopathy grade 0 or 1) - Your cancer has been assessed by a multidisciplinary team as suitable only for best supportive care (no other treatments available or chosen) - Your estimated life expectancy is at least 3 months **You may NOT be eligible if...** - You have moderate-to-severe cirrhosis (Child Pugh B or C) - You have significant mental confusion caused by liver disease (encephalopathy grade 2 or above) - You are unwilling or unable to attend follow-up appointments Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMedical Cannabis

Medical cannabis oil three times daily


Locations(1)

University Medical Center Groningen

Groningen, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06518434


Related Trials